TSE:4502Pharmaceuticals
Takeda Workforce Cuts Reshape Costs While Valuation Signals Possible Upside
Takeda Pharmaceutical (TSE:4502) announced a large-scale workforce reduction of about 4,500 roles as part of a broad corporate transformation program.
The company outlined associated restructuring costs alongside plans for long-term cost savings and operational changes.
Management framed the move as a response to competitive pressures and ongoing legal challenges affecting the business.
Takeda, a global pharmaceutical group with a focus on prescription medicines, vaccines, and specialty...